Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF

Newron Pharmaceuticals SpA (NWPHF) Technical Analysis

9 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
12Bullish
1Neutral
2Bearish
Technical Analysis Consensus
Strong Buy
2Bullish
1Neutral
0Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Newron Pharmaceuticals SpA’s (NWPHF) Moving Averages Convergence Divergence (MACD) indicator is 0.19, suggesting Newron Pharmaceuticals SpA is a Buy.
Newron Pharmaceuticals SpA’s (NWPHF) 20-Day exponential moving average is 11.87, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $12, making it a Buy.
Newron Pharmaceuticals SpA’s (NWPHF) 50-Day exponential moving average is 11.35, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $12, making it a Buy.

Newron Pharmaceuticals SpA (NWPHF) Pivot Points

Jul 26, 2024, 08:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.00
12.00
12.00
12.00
12.00
12.00
12.00
Fibonacci
12.00
12.00
12.00
12.00
12.00
12.00
12.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Newron Pharmaceuticals SpA (NWPHF) Moving Averages

Jul 26, 2024, 08:23 AM
Period
Simple
Exponential
MA5
12.00Buy
12.00Buy
MA10
12.00Sell
11.99Buy
MA20
12.00Sell
11.87Buy
MA50
11.63Buy
11.35Buy
MA100
10.22Buy
10.42Buy
MA200
8.62Buy
8.79Buy
Newron Pharmaceuticals SpA’s (NWPHF) 10-Day exponential moving average is 11.99, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $12, making it a Buy.
Newron Pharmaceuticals SpA’s (NWPHF) 100-Day exponential moving average is 10.42, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $12, making it a Buy.
Newron Pharmaceuticals SpA’s (NWPHF) stock price is $12 and Newron Pharmaceuticals SpA’s (NWPHF) 50-day simple moving average is 11.63, creating a Buy signal.
Newron Pharmaceuticals SpA’s (NWPHF) stock price is $12 and Newron Pharmaceuticals SpA’s (NWPHF) 100-day simple moving average is 10.22, creating a Buy signal.
Newron Pharmaceuticals SpA’s (NWPHF) stock price is $12 and Newron Pharmaceuticals SpA’s (NWPHF) 200-day simple moving average is 8.62, creating a Buy signal.

Newron Pharmaceuticals SpA (NWPHF) Technical Indicators

Jul 26, 2024, 08:23 AM
Name
Value
Implied Action
RSI (14)
66.86
Neutral
STOCH (9,6)
0.00
-
STOCHRSI (14)
0.00
-
MACD (12,26)
0.19
Buy
CCI (14)
0.00
-
ATR (14)
0.05
-
ROC
0.00
-
Bull/Bear Power (13)
0.08
Buy
Newron Pharmaceuticals SpA’s (NWPHF) Relative Strength Index (RSI) is 66.86, creating a Neutral signal.

FAQ

Is NWPHF a Buy, Hold, or Sell?
Based on NWPHF’s technical indicators, NWPHF is a Strong Buy.
    What is NWPHF’s RSI (14)?
    NWPHF’s RSI (14) is 66.86, which suggests NWPHF is a Neutral.
      What is NWPHF’s MACD?
      NWPHF’s MACD is 0.19, which suggests NWPHF is a Buy.
        What is NWPHF’s 5-day moving average?
        NWPHF’s 5-day moving average is 12.00, which suggests NWPHF is a Buy.
          What is NWPHF’s 20-day moving average?
          NWPHF 20-day moving average is 12.00, which suggests NWPHF is a Sell.
            What is NWPHF’s 50-day moving average?
            NWPHF’s 50-day moving average is 11.63, which suggests NWPHF is a Buy.
              What is NWPHF’s 200-day moving average?
              NWPHF’s 200-day moving average is 8.62, which suggests NWPHF is a Buy.
                What is NWPHF’s Williams % R (14)?
                Currently, no data Available
                What is NWPHF’s CCI (14)?
                Currently, no data Available
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis